SCHEMBL12818542

SCHEMBL12818542

N#Cc1ccc(-c2ccc3c(c2)N(S(=O)(=O)c2ccc4oncc4c2)CCO3)s1

nearest known ligand 0.38

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ PGR P06401 1/20 0.38
▸ MEN1 O00255 4/20 0.37
▸ KMT2A Q03164 4/20 0.37
▸ CYP2C9 P11712 1/20 0.35
▸ MAPT P10636 2/20 0.35
▸ TP53 P04637 1/20 0.34
▸ PDE3B Q13370 4/20 0.34
▸ PDE3A Q14432 4/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ PKM P14618 1/20 0.34
▸ PKLR P30613 1/20 0.34
▸ CPT1A P50416 4/20 0.34
▸ CPT1B Q92523 3/20 0.34
▸ NPC1 O15118 1/20 0.33
▸ CPT2 P23786 1/20 0.33
▸ GPR119 Q8TDV5 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1818351 0.85 PIK3CA (0.39) PGRMEN1KMT2ACYP2C9MAPT
SCHEMBL12818115 0.85 NPC1 (0.42) PGRMEN1KMT2ACYP2C9ALDH1A1
SCHEMBL12818426 0.84 PGR (0.59) PGRMEN1KMT2ACYP2C9ALDH1A1
SCHEMBL1818909 0.84 PKM (0.48) MEN1KMT2ACYP2C9ALDH1A1PKM
SCHEMBL12818531 0.84 PKM (0.45) PGRMEN1KMT2ACYP2C9PDE3B
SCHEMBL12817667 0.83 PGR (0.39) PGRMEN1KMT2ACYP2C9MAPT
SCHEMBL1818674 0.82 CYP2C9 (0.53) PGRMEN1KMT2ACYP2C9MAPT
SCHEMBL1820314 0.81 MEN1 (0.42) PGRMEN1KMT2ACYP2C9MAPT
SCHEMBL1819540 0.81 PKM (0.41) PGRMEN1KMT2ACYP2C9MAPT
SCHEMBL12818990 0.81 CYP2C9 (0.38) PGRMEN1KMT2ACYP2C9MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012130306-A1 BICYCLIC 2,3-DIHYRDOBENZAZINE COMPOUNDS FOR USE IN THERAPY ELARA PHARMACEUTICALS GMBH (DE) 2012-10-04 — — WO claimed
WO-2012130306-A1 BICYCLIC 2,3-DIHYRDOBENZAZINE COMPOUNDS FOR USE IN THERAPY ELARA PHARMACEUTICALS GMBH (DE) 2012-10-04 — — WO disclosed
Send feedback